#Oral_Cancer
LightNews LightNews
kourtidislab.bsky.social
Publication alert! The first part of the work by the talented DMD/PhD student in the lab Christina Kingsley is out in American Journal of Pathology, adding to our scarce knowledge on #RNAi the #oral stratified epithelium and #oral_cancer #cell_cell_junctions www.sciencedirect.com/science/arti...
Apical enrichment of the RNAi machinery in oral stratified epithelia is disrupted in oral cancer
Head and Neck Squamous Cell Carcinoma (HNSC) is characterized by low survival rates, which exposes gaps in our understanding of the disease. Although …
www.sciencedirect.com
May 10, 2026 at 4:52 PM
newsen.bsky.social
Innovative Strategies for Enhancing Oral Cancer Drug Delivery Effectiveness#Indonesia#Drug_Delivery#Oral_Cancer#Hasanuddin_University#Makassar
Innovative Strategies for Enhancing Oral Cancer Drug Delivery Effectiveness
This article explores new approaches to improve local drug delivery for oral cancer treatments, focusing on factors like formulation and tumor characteristics.
third-news.com
August 26, 2026 at 12:48 PM
newsen.bsky.social
Uncovering the Genetic Abnormalities of Oral Cancer: A Step Towards Early Diagnosis#Japan#genetic_research#Okayama#Oral_Cancer#Cuniculatum
Uncovering the Genetic Abnormalities of Oral Cancer: A Step Towards Early Diagnosis
A collaborative research team has shed light on the genetic abnormalities of the rare oral cancer 'Cuniculatum Carcinoma,' aiming for early diagnosis and treatment.
third-news.com
June 7, 2026 at 6:31 AM
newsen.bsky.social
Introducing VELscope Mantis: The Future of Oral Cancer Screening Technology in Dentistry#Canada#Vancouver#Oral_Cancer#VELscope#LED_Dental
Introducing VELscope Mantis: The Future of Oral Cancer Screening Technology in Dentistry
LED Dental unveils the VELscope Mantis, a revolutionary cordless device for oral cancer detection, enhancing visualization with three modes for better diagnostics.
third-news.com
June 4, 2026 at 1:00 PM
newsen.bsky.social
Importance of Early Oral Cancer Detection to Improve Survival Rates#United_States#Rosemont#Health_Awareness#AAOMS#Oral_Cancer
Importance of Early Oral Cancer Detection to Improve Survival Rates
The American Association of Oral and Maxillofacial Surgeons emphasizes the significance of early detection of oral cancers to boost survival rates. Self-examinations and regular screenings are crucial.
third-news.com
April 3, 2026 at 12:36 PM
newsen.bsky.social
Head and Neck Cancer Foundation Offers Free Screening Events for Early Detection Nationwide#United_States#Various_States#Health_Awareness#Head_and_Neck_Cancer#Oral_Cancer
Head and Neck Cancer Foundation Offers Free Screening Events for Early Detection Nationwide
Join the Head and Neck Cancer Foundation's free oral cancer screening events from April 13-17 for awareness and early detection across 19 states.
third-news.com
March 30, 2026 at 10:17 AM
newsen.bsky.social
Privo Technologies Commences First Human Dosing of PRV131 in Pioneering Oral Cancer Treatment Trial#USA#Boston#Privo_Technologies#Oral_Cancer#PRV131
Privo Technologies Commences First Human Dosing of PRV131 in Pioneering Oral Cancer Treatment Trial
Privo Technologies has officially begun dosing its first patient in a groundbreaking clinical trial for PRV131, an innovative injectable for oral cavity cancer, showcasing phase 1/2 advancements.
third-news.com
December 10, 2025 at 8:19 PM
newsen.bsky.social
PRV111: A Game-Changer in Non-Surgical Treatment for Oral Cancer#USA#Peabody#Privo_Technologies#PRV111#Oral_Cancer
PRV111: A Game-Changer in Non-Surgical Treatment for Oral Cancer
PRV111 shows promise as a non-surgical therapy for early-stage oral cancer with a remarkable 92% complete response rate in clinical trials. Explore its groundbreaking potential.
third-news.com
November 17, 2025 at 3:51 PM
newsen.bsky.social
Privo Technologies Completes Milestone in Oral Cancer Treatment Trial with PRV111#United_States#Peabody#Privo_Technologies#PRV111#Oral_Cancer
Privo Technologies Completes Milestone in Oral Cancer Treatment Trial with PRV111
Privo Technologies announces the completion of enrollment in the Phase 2 run-in of its PRV111 trial, aimed at reducing surgery for oral cancer patients.
third-news.com
October 14, 2025 at 6:18 PM